Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening

Vox Sanguinis

Volumn 84, Issue 4, 2003, Pages 287-291

  Minegishi, K ^a   Yoshikawa, A ^b,e   Kishimoto, S ^b   Yugi, H ^c   Yokoya, N ^c   Sakurada, M ^d   Kiyokawa, H ^a   Nishioka, K ^a  

^a Blood Services Department   (Japan)

^b JRC Saitama Blood Center   (Japan)

^c Japanese Red Cross Society   (Japan)

^d Japanese Red Cross Society   (Japan)

^e JAPANESE RED CROSS SOCIETY   (Japan)

Author keywords

Chemiluminescence immunoassay; CLIA; HBsAg screening; HBV DNA; Minipool NAT

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

AGGLUTINATION TEST; ARTICLE; BLOOD; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CHEMOLUMINESCENCE; ENZYME IMMUNOASSAY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; JAPAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; RED CROSS; SAFETY; SCREENING; SENSITIVITY AND SPECIFICITY; SEROLOGY; VIRUS LOAD;

BLOOD DONORS; CHEMILUMINESCENT MEASUREMENTS; DNA, VIRAL; FALSE NEGATIVE REACTIONS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOASSAY; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 0038795407     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2003.00289.x     Document Type: Article

References (13)

1. Otake K, Nishioka K: Nucleic acid amplification testing of hepatitis B virus. Lancet 2000; 355:1460
2. Japanese Red Cross NAT Screening Research Group: Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors. Jpn J Infect Dis 2000; 53:116-123
3. Japanese Red Cross NAT Screening Research Group: The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, HIV-1 and significance of NAT for HBV. Microbiol Immunol 2001; 45:667-672
4. Meng O, Wong C, Rangachari A, Tamatsukuri S, Sasaki M, Fiss E, Cheng L, Ramankutty T, Clarke D, Yawata H, Sasakura Y, Hirose T, Impraim C: Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA and human immunodeficiency virus type 1 RNA. J Clin Microbiol 2001; 39:2937-2945
5. International Forum: Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology. Vox Sang 2002; 82:87-111
6. Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M: Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63:107-111
7. Japanese Red Cross Non-A Non-B Hepatitis Research Group: Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 1991; 338:1040-1041
8. Takeda Y, Wakisaka A, Noguchi K, Murozuka T, Katsubayashi Y, Matsumoto S, Tomono T, Nishioka K: Receptor-mediated haemagglutination screening and reduction in the viral load of parvovirus B19 DNA in immunopurified Factor VIII concentrate (Cross Eight M). Vox Sang 2001; 81:266-268
9. Saecher RA, Schleiber GB, Kleinman SH: Prevention of transfusion-transmitted hepatitis. Lancet 2000; 355:331-332
10. Kleinman SH, Busch MP: HBV amplified and back in the blood safety spotlight. Transfusion 2001; 41:1081-1085
11. Stramer SL, Brodsky JP, Preston SB, Kuhns MC, Pierce MP, Smith RI: Comparative sensitivity of HBsAg and HBV NAT. Transfusion 2001; 41:8S-9S
12. Biswas R, Busch M, Wright D, Epstein J, Tabor E: Early detection of hepatitis B virus infection: comparative sensitivity of HBV DNA detection by PCR and HBsAg detection by a new generation of assays. Hepatology 2001; 34:610A
13. Weusten JJAM, Drimmelen HAJ, Lelie PN: Mathematic modeling of the risk of HBV, HCV and HIV transmission by window-phase donations not detected by NAT. Transfusion 2002; 42:537-548